123 related articles for article (PubMed ID: 23540644)
1. Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.
Song J; Jones LM; Chavarria GE; Charlton-Sevcik AK; Jantz A; Johansen A; Bayeh L; Soeung V; Snyder LK; Lade SD; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2013 May; 23(9):2801-7. PubMed ID: 23540644
[TBL] [Abstract][Full Text] [Related]
2. Novel peptidyl aryl vinyl sulfones as highly potent and selective inhibitors of cathepsins L and B.
Mendieta L; Picó A; Tarragó T; Teixidó M; Castillo M; Rafecas L; Moyano A; Giralt E
ChemMedChem; 2010 Sep; 5(9):1556-67. PubMed ID: 20652927
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
Kishore Kumar GD; Chavarria GE; Charlton-Sevcik AK; Arispe WM; Macdonough MT; Strecker TE; Chen SE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2010 Feb; 20(4):1415-9. PubMed ID: 20089402
[TBL] [Abstract][Full Text] [Related]
5. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
Raghav N; Singh M
Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
[TBL] [Abstract][Full Text] [Related]
6. Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.
Kumar GD; Chavarria GE; Charlton-Sevcik AK; Yoo GK; Song J; Strecker TE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2010 Nov; 20(22):6610-5. PubMed ID: 20933415
[TBL] [Abstract][Full Text] [Related]
7. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
Garg S; Raghav N
Bioorg Chem; 2016 Aug; 67():64-74. PubMed ID: 27285276
[TBL] [Abstract][Full Text] [Related]
8. SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
Raghav N; Singh M
Bioorg Med Chem; 2014 Aug; 22(15):4233-45. PubMed ID: 24913985
[TBL] [Abstract][Full Text] [Related]
9. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors.
Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M
ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279
[TBL] [Abstract][Full Text] [Related]
10. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
Torkar A; Lenarčič B; Lah T; Dive V; Devel L
Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.
Song J; Jones LM; Kumar GD; Conner ES; Bayeh L; Chavarria GE; Charlton-Sevcik AK; Chen SE; Chaplin DJ; Trawick ML; Pinney KG
ACS Med Chem Lett; 2012 Jun; 3(6):450-3. PubMed ID: 24900494
[TBL] [Abstract][Full Text] [Related]
12. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
Raghav N; Jangra S; Kumar A; Bhattacharyya S
Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
[TBL] [Abstract][Full Text] [Related]
14. Some thiocarbamoyl based novel anticathepsin agents.
Kaur R; Raghav N
Bioorg Chem; 2020 Nov; 104():104174. PubMed ID: 32932119
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B and L inhibitors: a patent review (2010 - present).
Li YY; Fang J; Ao GZ
Expert Opin Ther Pat; 2017 Jun; 27(6):643-656. PubMed ID: 27998201
[TBL] [Abstract][Full Text] [Related]
16. Repurposing de novo designed entities reveals phosphodiesterase 3B and cathepsin L modulators.
Rodrigues T; Lin YC; Hartenfeller M; Renner S; Lim YF; Schneider G
Chem Commun (Camb); 2015 May; 51(35):7478-81. PubMed ID: 25828577
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
Baek KH; Karki R; Lee ES; Na Y; Kwon Y
Bioorg Chem; 2013 Dec; 51():24-30. PubMed ID: 24095934
[TBL] [Abstract][Full Text] [Related]
18. Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
Kerns JK; Nie H; Bondinell W; Widdowson KL; Yamashita DS; Rahman A; Podolin PL; Carpenter DC; Jin Q; Riflade B; Dong X; Nevins N; Keller PM; Mitchell L; Tomaszek T
Bioorg Med Chem Lett; 2011 Aug; 21(15):4409-15. PubMed ID: 21733692
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents.
Ettari R; Pinto A; Tamborini L; Angelo IC; Grasso S; Zappalà M; Capodicasa N; Yzeiraj L; Gruber E; Aminake MN; Pradel G; Schirmeister T; De Micheli C; Conti P
ChemMedChem; 2014 Aug; 9(8):1817-25. PubMed ID: 24919925
[TBL] [Abstract][Full Text] [Related]
20. Structure-guided development of selective TbcatB inhibitors.
Mallari JP; Shelat AA; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
J Med Chem; 2009 Oct; 52(20):6489-93. PubMed ID: 19769357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
